ORCHARD THERAPEUTICS PLC Share-based Payment Arrangement, Expense
ORCHARD THERAPEUTICS PLC reported Share-based Payment Arrangement, Expense of $2.47 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-11-13
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for the quarter ending 2023-09-30 was $2.47M, a 28.84% decline year-over-year.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for the quarter ending 2023-06-30 was $2.58M, a 34.83% decline year-over-year.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for the quarter ending 2023-03-31 was $3.51M, a 24.64% decline year-over-year.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for the quarter ending 2022-12-31 was $3.93M, a 26.45% decline year-over-year.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for fiscal 2022 was $16.01M, a 28.96% decline from fiscal 2021.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for fiscal 2021 was $22.54M, a 19.40% decline from fiscal 2020.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for fiscal 2020 was $27.96M, a 43.96% increase from fiscal 2019.
- ORCHARD THERAPEUTICS PLC share-based payment arrangement, expense for fiscal 2019 was $19.42M, a 187.08% increase from fiscal 2018.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-09-30 | $2.47M 10-Q · filed 2023-11-13 | $5.05M derived: sum of 2 quarters · filed 2023-11-13 | $8.56M 10-Q · filed 2023-11-13 | $12.48M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $2.58M 10-Q · filed 2023-08-10 | $6.09M 10-Q · filed 2023-08-10 | $10.02M derived: sum of 3 quarters · filed 2023-08-10 | $13.48M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $3.51M 10-Q · filed 2023-05-15 | $7.44M derived: sum of 2 quarters · filed 2023-05-15 | $10.91M derived: sum of 3 quarters · filed 2023-11-13 | $14.86M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $7.39M derived: sum of 2 quarters · filed 2023-11-13 | $11.35M derived: sum of 3 quarters · filed 2023-11-13 | $16.01M 10-K · filed 2023-03-14 |
| 2022-09-30 | $3.47M 10-Q · filed 2023-11-13 | $7.42M derived: sum of 2 quarters · filed 2023-11-13 | $12.08M 10-Q · filed 2023-11-13 | $17.42M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $3.96M 10-Q · filed 2023-08-10 | $8.62M 10-Q · filed 2023-08-10 | $13.95M derived: sum of 3 quarters · filed 2023-08-10 | $19.34M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $4.66M 10-Q · filed 2023-05-15 | $10.00M derived: sum of 2 quarters · filed 2023-05-15 | $15.39M derived: sum of 3 quarters · filed 2023-05-15 | $20.93M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $10.73M derived: sum of 2 quarters · filed 2023-03-14 | $16.27M derived: sum of 3 quarters · filed 2023-03-14 | $22.54M 10-K · filed 2023-03-14 |
| 2021-09-30 | $5.39M 10-Q · filed 2022-11-14 | $10.93M derived: sum of 2 quarters · filed 2022-11-14 | $17.20M 10-Q · filed 2022-11-14 | $23.94M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $5.54M 10-Q · filed 2022-08-04 | $11.81M 10-Q · filed 2022-08-04 | $18.55M derived: sum of 3 quarters · filed 2022-08-04 | $24.21M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $6.27M 10-Q · filed 2022-05-12 | $13.01M derived: sum of 2 quarters · filed 2022-05-12 | $18.67M derived: sum of 3 quarters · filed 2022-05-12 | $24.75M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $6.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $12.40M derived: sum of 2 quarters · filed 2022-03-30 | $18.48M derived: sum of 3 quarters · filed 2022-03-30 | $27.96M 10-K · filed 2022-03-30 |
| 2020-09-30 | $5.66M 10-Q · filed 2021-11-04 | $11.74M derived: sum of 2 quarters · filed 2021-11-04 | $21.22M 10-Q · filed 2021-11-04 | $26.89M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $6.08M 10-Q · filed 2021-08-04 | $15.56M 10-Q · filed 2021-08-04 | $21.23M derived: sum of 3 quarters · filed 2021-08-04 | $26.53M derived: sum of 4 quarters · filed 2021-08-04 |
| 2020-03-31 | $9.48M 10-Q · filed 2021-05-13 | $15.15M derived: sum of 2 quarters · filed 2021-05-13 | $20.45M derived: sum of 3 quarters · filed 2021-05-13 | $25.08M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $5.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $10.97M derived: sum of 2 quarters · filed 2021-03-02 | $15.60M derived: sum of 3 quarters · filed 2021-03-02 | $19.42M 10-K · filed 2021-03-02 |
| 2019-09-30 | $5.30M 10-Q · filed 2020-11-03 | $9.93M derived: sum of 2 quarters · filed 2020-11-03 | $13.75M 10-Q · filed 2020-11-03 | $16.56M derived: sum of 4 quarters · filed 2020-11-03 |
| 2019-06-30 | $4.63M 10-Q · filed 2020-08-06 | $8.45M 10-Q · filed 2020-08-06 | $11.26M derived: sum of 3 quarters · filed 2020-08-06 | $12.97M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $3.82M 10-Q · filed 2020-05-07 | $6.63M derived: sum of 2 quarters · filed 2020-05-07 | $8.34M derived: sum of 3 quarters · filed 2020-05-07 | $9.48M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $2.81M derived: 10-K 12 month − 6-K 9 month · filed 2020-02-27 | $4.52M derived: sum of 2 quarters · filed 2020-02-27 | $5.66M derived: sum of 3 quarters · filed 2020-02-27 | $6.77M 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.71M derived: 6-K 9 month − 6-K 6 month · filed 2019-11-07 | $2.85M derived: sum of 2 quarters · filed 2019-11-07 | $3.96M 6-K · filed 2019-11-07 | |
| 2018-06-30 | $1.15M derived: 6-K 6 month − 6-K 3 month · filed 2019-08-08 | $2.25M 6-K · filed 2019-08-08 | ||
| 2018-03-31 | $1.10M 6-K · filed 2019-05-28 | |||
| 2017-12-31 | $1.02M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $204.00K 20-F · filed 2019-03-22 |